Eupraxia Pharmaceuticals Inc. (EPRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 88.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -88.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 15.65M | 16.16M | 6.88M | 11.26M | 10.15M | 10.76M | 8.51M | 8.96M | 6.69M | 12.16M | 6.44M | 5.71M | 3.54M | 6.57M | 3.54M | 4.77M | 2.72M | 2.7M | 3.97M | 4.01M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 4.7M | 8.3M | 2.47M | 4.18M | 4.66M | 5.18M | 3.02M | 3.53M | 2.52M | 1.78M | 2.52M | 1.92M | 1.26M | 1.68M | 689.34K | 917.98K | 1.13M | 1.24M | 1.16M | 1.07M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 10.95M | 7.87M | 4.42M | 7.08M | 5.48M | 5.58M | 5.5M | 5.43M | 4.18M | 10.49M | 3.81M | 3.79M | 2.27M | 4.85M | 2.82M | 3.81M | 1.56M | 1.44M | 2.79M | 2.92M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -108.67K | 108.67K | 0 | 0 | 41.39K | 36.48K | 37.95K | 31.53K | 32.5K | 23.18K | 16.38K |
| Operating Income | -15.74M | -16.16M | -6.88M | -11.26M | -10.15M | -10.76M | -8.51M | -8.96M | -6.69M | -12.16M | -6.44M | -5.71M | -3.54M | -6.57M | -3.54M | -4.77M | -2.72M | -2.7M | -3.97M | -4.01M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -55.1% | -50.22% | 19.15% | -25.59% | -51.58% | 11.54% | -32.22% | -57.01% | -89.27% | -85.24% | -81.75% | -19.77% | -30.18% | -142.84% | 10.75% | -18.73% | 34% | -2263.75% | -936.27% | - |
| EBITDA | -15.65M | -16.09M | -6.82M | -11.18M | -10.08M | -10.68M | -8.46M | -8.91M | -6.66M | -12.12M | -6.41M | -5.67M | -3.5M | -6.52M | -3.51M | -4.73M | -2.69M | -2.67M | -3.95M | -4M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -55.24% | -50.64% | 19.4% | -25.55% | -51.43% | 11.84% | -32.11% | -57.05% | -90.23% | -85.69% | -82.49% | -19.9% | -30.32% | -144.24% | 11.07% | -18.3% | 34.51% | -2757.85% | -977.58% | - |
| D&A (Non-Cash Add-back) | 88.9K | 72.81K | 62.99K | 75.52K | 66.2K | 78.39K | 51.24K | 57.48K | 37.42K | 46.86K | 33.09K | 38.12K | 37.46K | 41.39K | 32.52K | 36.97K | 31.53K | 32.5K | 22.27K | 16.67K |
| EBIT | -15.74M | -16.71M | -6.37M | -11.91M | -9.63M | -10.83M | -8.13M | -7.91M | -5.83M | -10.57M | -4.32M | -9.2M | -3.66M | -6.43M | -3.69M | -4.59M | -2.74M | -2.7M | -3.77M | -4.36M |
| Net Interest Income | 1.06M | 666.92K | 180.19K | 348.72K | 440.69K | 313.31K | 412.41K | 163.27K | -84.77K | 103.08K | -132.34K | -149.5K | -128.44K | -178.54K | -109.14K | -198.26K | -239.72K | -239.26K | -238.97K | -136.66K |
| Interest Income | 1.06M | 666.92K | 180.19K | 348.72K | 440.69K | 313.51K | 413.02K | 548.73K | 236.37K | 358.88K | 188.79K | 152.27K | 163.03K | 169.39K | 140.82K | 88.57K | 28.28K | 24.92K | 15.01K | 11.88K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 197 | 612 | 385.46K | 321.14K | 255.8K | 321.13K | 301.77K | 291.48K | 347.93K | 249.96K | 286.84K | 268K | 264.18K | 253.98K | 148.53K |
| Other Income/Expense | 3.27M | -547.38K | 513.12K | -651.25K | 512.31K | -70.36K | 382.57K | 664.95K | 541.54K | 1.59M | 1.54M | -3.8M | -419.63K | -209.66K | -398.3K | -106.47K | -294.79K | -264.99K | -56.93K | -497.41K |
| Pretax Income | -12.47M | -16.71M | -6.37M | -11.91M | -9.63M | -10.83M | -8.13M | -8.3M | -6.15M | -10.57M | -4.9M | -9.51M | -3.96M | -6.78M | -3.94M | -4.87M | -3.01M | -2.97M | -4.03M | -4.51M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 13.71K | 11.34K | -623 | 7.6K | 3.98K | 2.59K | 0 | -6.84K | 5K | 36.42K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -0.11% | -0.07% | 0.01% | -0.06% | -0.04% | -0.02% | 0% | 0.08% | -0.08% | -0.34% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -12.48M | -16.71M | -6.36M | -11.91M | -9.63M | -10.8M | -8.07M | -8.22M | -6.04M | -10.23M | -4.72M | -9.38M | -3.9M | -6.58M | -3.84M | -4.73M | -2.96M | -2.92M | -3.9M | -4.38M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -29.57% | -54.75% | 21.13% | -44.95% | -59.37% | -5.59% | -70.83% | 12.39% | -55.13% | -55.39% | -22.98% | -98.4% | -31.77% | -125.23% | 1.56% | -7.79% | 57.88% | -1062.52% | -614.68% | - |
| Net Income (Continuing) | -12.48M | -16.72M | -6.37M | -11.92M | -9.64M | -10.83M | -8.13M | -8.29M | -6.16M | -10.61M | -4.9M | -9.51M | -3.96M | -6.78M | -3.94M | -4.87M | -3.01M | -2.97M | -4.03M | -4.51M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -1.6M | -1.6M | -2.21M | -1.58M | -1.57M | -1.57M | -1.54M | -1.49M | -1.44M | -1.32M | -1.98M | -1.75M | -1.57M | -783.49K | -1.23M | -1.09M | -902.6K | -833.84K | -774.54K | -613.75K |
| EPS (Diluted) | -0.23 | -0.34 | -0.26 | -0.33 | -0.30 | -0.21 | -0.17 | -0.17 | -0.21 | -0.15 | -0.41 | -0.43 | -0.18 | -0.41 | -0.22 | -0.31 | -0.26 | -0.30 | -0.35 | -0.41 |
| EPS Growth % | 23.33% | -61.9% | -52.94% | -94.12% | -42.86% | -40% | 58.54% | 60.47% | -16.67% | 63.41% | -86.36% | -38.71% | 30.77% | -36.67% | 37.14% | 24.39% | 61.76% | -2703.74% | -324.76% | - |
| EPS (Basic) | -0.23 | -0.34 | -0.19 | -0.33 | -0.30 | -0.21 | -0.17 | -0.17 | -0.21 | -0.15 | -0.41 | -0.43 | -0.18 | -0.41 | -0.22 | -0.31 | -0.26 | -0.30 | -0.35 | -0.41 |
| Diluted Shares Outstanding | 56.71M | 51.94M | 36.92M | 35.91M | 35.69M | 35.62M | 35.62M | 35.62M | 28.81M | 24.15M | 27.31M | 22.01M | 21.7M | 21.59M | 21.39M | 19.9M | 14.24M | 12.41M | 14.24M | 13.23M |
| Basic Shares Outstanding | 56.71M | 51.94M | 33.48M | 35.91M | 35.69M | 35.62M | 35.62M | 35.62M | 28.81M | 24.15M | 27.31M | 22.01M | 21.7M | 21.59M | 21.39M | 19.9M | 14.24M | 12.41M | 14.24M | 13.23M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |